    [Federal Register Volume 85, Number 168 (Friday, August 28, 2020)]
    [Notices]
    [Pages 53385-53386]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 2020-18917]

    -----------------------------------------------------------------------

    DEPARTMENT OF HEALTH AND HUMAN SERVICES

    Meeting of the National Clinical Care Commission

    AGENCY: Office of Disease Prevention and Health Promotion, Office of
    the Assistant Secretary for Health, Office of the Secretary, Department
    of Health and Human Services.

    ACTION: Notice.

    -----------------------------------------------------------------------

    SUMMARY: The National Clinical Care Commission (the Commission) will
    conduct a virtual meeting on September 11, 2020. The Commission is
    charged to evaluate and make recommendations to the U.S. Department of
    Health and Human Services (HHS) Secretary and Congress regarding
    improvements to the coordination and leveraging of federal programs
    related to diabetes and its complications.

    DATES: The meeting will take place on September 11, 2020, from 1 p.m.
    to approximately 5:30 p.m. Eastern Daylight time (EDT).

    ADDRESSES: The meeting will be held online via webinar. To register to
    attend the meeting, please visit the registration website at https://kauffmaninc.adobeconnect.com/nccc_sept2020/event/event_info.html.

    FOR FURTHER INFORMATION CONTACT: Jennifer Anne Bishop, ScD, MPH,
    Designated Federal Officer, National Clinical Care Commission, U.S.
    Department of Health and Human Services, Office of the Assistant

    [[Page 53386]]

    Secretary for Health, Office of Disease Prevention and Health
    Promotion, 1101 Wootton Parkway, Suite 420, Rockville, MD 20852. Phone:
    (240) 453-8826. Email: OHQ@hhs.gov.

    SUPPLEMENTARY INFORMATION: The National Clinical Care Commission Act
    (Pub. L. 115-80) requires the HHS Secretary to establish the National
    Clinical Care Commission. The Commission consists of representatives of
    specific federal agencies and non-federal individuals and entities who
    represent diverse disciplines and views. The Commission will evaluate
    and make recommendations to the HHS Secretary and Congress regarding
    improvements to the coordination and leveraging of federal programs
    related to diabetes and its complications.
        The eighth meeting will be held virtually, and will consist of
    updates from the Commission's three subcommittees and a discussion of
    public comments and outreach to stakeholder organizations.
    Additionally, the first round of potential ``action plans'' from the
    subcommittee (i.e., recommendations) to be discussed by Commission. The
    final meeting agenda will be available prior to the meeting at https://health.gov/our-work/health-care-quality/national-clinical-care-commission/meetings.
        Public Participation at Meeting: The Commission invites public
    comment on issues related to the Commission's charge. There will be an
    opportunity for limited oral comments (each no more than 3 minutes in
    length) at this virtual meeting. Virtual attendees who plan to provide
    oral comments at the Commission meeting during a designated time must
    register prior to the meeting at https://kauffmaninc.adobeconnect.com/nccc_sept2020/event/event_info.html.
        Written comments are welcome throughout the entire development
    process of the Commission's work and may be emailed to OHQ@hhs.gov.
    Written comments should not exceed three pages in length.
        Individuals who need special assistance, such as sign language
    interpretation or other reasonable accommodations, should indicate the
    special accommodation when registering online or by notifying Jennifer
    Gillissen at jennifer.gillissen@kauffmaninc.com by August 27, 2020.
        Authority: The National Clinical Care Commission is required under
    the National Clinical Care Commission Act (Pub. L. 115-80). The
    Commission is governed by provisions of the Federal Advisory Committee
    Act (FACA), Public Law 92-463, as amended (5 U.S.C., App.) which sets
    forth standards for the formation and use of federal advisory
    committees.

        Dated: August 24, 2020.
    Paul Reed,
    Deputy Assistant Secretary for Health, Acting Director, Office of
    Disease Prevention and Health Promotion, Office of the Assistant
    Secretary for Health.
    [FR Doc. 2020-18917 Filed 8-27-20; 8:45 am]
    BILLING CODE 4150-32-P